Literature DB >> 15188059

Human recombinant B7-H3 expressed in E. coli enhances T lymphocyte proliferation and IL-10 secretion in vitro.

Guang-Bo Zhang1, Yong-Jing Chen, Qin Shi, Hong-Bing Ma, Yan Ge, Qin Wang, Zhi Jiang, Ying Xu, Xue-Guang Zhang.   

Abstract

To explore the biofunctions of human B7-H3 on activated T lymphocyte, the gene of human B7-H3 encoding the extracellular region (IgV-like and IgC-like domains) was obtained by RT-PCR from human lung cells and subcloned into the prokaryotic expression vector pGEX-5X-3 to express glutathione S-transferase (GST) fusion protein. A 49 kD fusion protein (named as GST/hB7-H3 hereafter) was induced by IPTG and purified by standard methods reported in prokaryotic system. In the presence of the first signal imitated by anti-CD3 monoclonal antibody, T lymphocyte proliferation was observed by incubating purified T cells with soluble GST/hB7-H3 fusion protein by MTT assay. The concentrations of IFN-gamma and IL-10 in the supernatants of T cells were determined by ELISA. The results showed that the GST/hB7-H3 protein produced in bacteria had modest biological activities to proliferate the T lymphocyte and enhance IFN-gamma as well as IL-10 secretion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188059     DOI: 10.1093/abbs/36.6.430

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  9 in total

1.  Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.

Authors:  Guangbo Zhang; Jianquan Hou; Jinfang Shi; Gehua Yu; Binfeng Lu; Xueguang Zhang
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

Review 2.  New B7 Family Checkpoints in Human Cancers.

Authors:  Ling Ni; Chen Dong
Journal:  Mol Cancer Ther       Date:  2017-07       Impact factor: 6.261

3.  B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.

Authors:  Judith Leitner; Christoph Klauser; Winfried F Pickl; Johannes Stöckl; Otto Majdic; Anaïs F Bardet; David P Kreil; Chen Dong; Tomohide Yamazaki; Gerhard Zlabinger; Katharina Pfistershammer; Peter Steinberger
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

4.  Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system.

Authors:  Jing Sun; Fengqing Fu; Wenchao Gu; Ruhong Yan; Guangbo Zhang; Zhiyong Shen; Yinghui Zhou; Han Wang; Bairong Shen; Xueguang Zhang
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

5.  Cloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activation.

Authors:  Weiwei Chen; Zhibo Hou; Chunman Li; Sheng Xiong; Henggui Liu
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

Review 6.  Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.

Authors:  Nan Li; Madeline R Spetz; Dan Li; Mitchell Ho
Journal:  Pharmacol Ther       Date:  2021-05-14       Impact factor: 13.400

7.  Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.

Authors:  Tomoki Ito; Maria Yang; Yui-Hsi Wang; Roberto Lande; Josh Gregorio; Olivia A Perng; Xiao-Feng Qin; Yong-Jun Liu; Michel Gilliet
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

Review 8.  Potential Therapeutic Targets of B7 Family in Colorectal Cancer.

Authors:  Changgang Wang; Haoran Feng; Xi Cheng; Kun Liu; Dongli Cai; Ren Zhao
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

9.  Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.

Authors:  Weiwei Chen; Peixin Liu; Yedong Wang; Weimin Nie; Zhiwei Li; Wen Xu; Fengyi Li; Zhiping Zhou; Min Zhao; Henggui Liu
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.